Asphyxiation by laryngeal edema in patients with hereditary angioedema.

OBJECTIVE To describe the occurrence of fatal laryngeal edema in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. PATIENTS AND METHODS We describe 6 patients from various regions of Germany who died from laryngeal edema within the last 10 years. Furthermore, we conducted a retrospective survey of 58 patients with hereditary angioedema, originating from 46 affected families. The data were obtained from the attending physicians and from the patients' relatives. RESULTS Among the 6 reported patients, aged 9 to 78 years, hereditary angioedema had been diagnosed in 3 and was undiagnosed in 3. None of them had an emergency cricothyrotomy or received C1 inhibitor concentrate. The interval between onset of the laryngeal edema and asphyxiation was 20 minutes in a 9-year-old boy, and in the other patients, the interval was 1 to 14 hours (mean for all, 7 hours). The retrospective survey of 58 patients with hereditary angioedema revealed 23 deaths by asphyxiation (40%). The average age of all 29 patients at the time of asphyxiation was 39 years. CONCLUSION Laryngeal edema in hereditary angioedema may be fatal. Most of the patients asphyxiated between their 20th and 50th years of life, but asphyxiation can occur even in children. The possibility that the first episode of laryngeal edema may be fatal must be emphasized to the relatives, and attending physicians must have a high degree of awareness.

[1]  K. Bork,et al.  Aszites und vermeintliches akutes Abdomen bei hereditärem Angioödem durch C1-Inhibitor-Mangel , 2008 .

[2]  K. Bork,et al.  Hepatocellular adenomas in patients taking danazol for here ditary angiooedema , 1999, The Lancet.

[3]  C. Létoublon,et al.  Danazol therapy: an unusual aetiology of hepatocellular carcinoma. , 1998, Journal of hepatology.

[4]  J. Weiler,et al.  C1 Esterase Inhibitor Deficiency, Airway Compromise, and Anesthesia , 1998, Anesthesia and analgesia.

[5]  F. Rosen,et al.  A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema , 1998, Transfusion.

[6]  M. Cicardi,et al.  Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. , 1997, The Journal of allergy and clinical immunology.

[7]  F. Rosen,et al.  Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. , 1996, The New England journal of medicine.

[8]  J. Gran,et al.  Hereditary angio‐oedema: new clinical observations and autoimmune screening, complement and kallikrein‐kinin analyses , 1996, Journal of internal medicine.

[9]  J. Aaseth,et al.  [A fatal case of hereditary angioedema]. , 1995, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[10]  T. Mollnes,et al.  Effect of time, temperature and additives on a functional assay of C1 inhibitor. , 1994, Journal of immunological methods.

[11]  M. Cicardi,et al.  Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.

[12]  E. Hack,et al.  Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience. , 1991, The Journal of allergy and clinical immunology.

[13]  M. Frank,et al.  The long-term safety of danazol in women with hereditary angioedema. , 1990, Fertility and sterility.

[14]  J. Jespersen,et al.  Effects of methylamine and heparin on a rapid chromogenic assay of C1-esterase inhibitor in plasma. , 1990, Clinical chemistry.

[15]  K. Bork,et al.  Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. , 1989, The Journal of allergy and clinical immunology.

[16]  M. Kaliner,et al.  Management of the airway in patients with angioedema , 1983, The Laryngoscope.

[17]  M. Cicardi,et al.  Hereditary Angioedema: An Appraisal of 104 Cases , 1982, The American journal of the medical sciences.

[18]  J. Gelfand,et al.  Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. , 1980, The New England journal of medicine.

[19]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.

[20]  R. R. Evans,et al.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.

[21]  N. S. Landerman.  Hereditary angioneurotic edema. I. Case reports and review of the literature. , 1962, The Journal of allergy.

[22]  W. Spaulding,et al.  METHYLTESTOSTERONE THERAPY FOR HEREDITARY EPISODIC EDEMA (HEREDITARY ANGIONEUROTIC EDEMA) , 1960 .

[23]  W. Osler.  HEREDITARY ANGIO‐NEUROTIC ŒDEMA , 1888 .